retatrutide in south africa clinical trial Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver SA doctors caution against use
Description
While the term may sound highly technical, its mechanism is based on a simple principle: mimic the effects of a natural hormone that your body already produces, but amplify its benefits for weight loss and blood sugar control

For an adult who is 5 foot 8 inches tall, that's a weight of 197 pounds or more

Le-Vel likely recommends continuous use to maintain sales, but cycling off periodically might prevent tolerance while saving money

Vilsboll T, Krarup T, Madsbad S, Holst JJ (2002) Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients

Tirzepatide (Mounjaro, Zepbound) is technically a dual GIP/GLP-1 receptor agonist, hitting two incretin receptors instead of one, which explains its superior weight loss outcomes in clinical trials
If headaches persist or significantly affect your quality of life, talk to your healthcare provider
